These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Impetigo herpetiformis; acrodermatitis continua of Hallopeau and pustular psoriasis; etiology and pathogenesis and differential diagnosis]. GRANELLI U Minerva Dermatol; 1956 Apr; 31(4):120-6. PubMed ID: 13348185 [No Abstract] [Full Text] [Related]
5. Acrodermatitis pustulosa perstans; a method of treatment. FISHMAN HC AMA Arch Derm Syphilol; 1951 Jul; 64(1):56-8. PubMed ID: 14837495 [No Abstract] [Full Text] [Related]
6. Acrodermatitis pustulosa perstans; persistence for twenty-one years, since the age of three years. FISHMAN HC AMA Arch Derm Syphilol; 1951 Apr; 63(4):506. PubMed ID: 14810236 [No Abstract] [Full Text] [Related]
7. Acrodermatitis pustulosa perstans; report of a case in a child. SACHS W; FIELD H Arch Derm Syphilol; 1950 Feb; 61(2):319-22. PubMed ID: 15403974 [No Abstract] [Full Text] [Related]
8. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab. Yamamoto H; Kamiya K; Okada H; Maekawa T; Komine M; Ohtsuki M Int J Dermatol; 2023 Feb; 62(2):269-270. PubMed ID: 35187654 [No Abstract] [Full Text] [Related]
13. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau. Wang Y; Zhang L; Zheng J; Li X; Chen L JAMA Dermatol; 2024 Apr; 160(4):476-477. PubMed ID: 38416455 [TBL] [Abstract][Full Text] [Related]
15. [HALLOPEAU'S ACRODERMATITIS CONTINUA?PSORIASIS PUSTULOSA?CASE REPORT WITH SPECIAL REFERENCE TO TREATMENT RESULTS]. SCHAULOW I Dermatol Wochenschr; 1963 Mar; 147():264-9. PubMed ID: 14162987 [No Abstract] [Full Text] [Related]
16. Successful treatment of acrodermatitis continua of Hallopeau by TYK2 inhibitor with every other day. Kan Y; Uhara H J Dermatolog Treat; 2024 Dec; 35(1):2316239. PubMed ID: 38387442 [No Abstract] [Full Text] [Related]
17. Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? Megna M; Potestio L; Di Caprio N; Tajani A; Fabbrocini G; Annunziata A Dermatol Ther; 2022 May; 35(5):e15423. PubMed ID: 35261135 [No Abstract] [Full Text] [Related]
18. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab. Buononato D; Licata G; Gambardella A; De Rosa A; Calabrese G; Argenziano G Dermatol Ther; 2022 Jul; 35(7):e15514. PubMed ID: 35420733 [No Abstract] [Full Text] [Related]
19. Successful therapy of acrodermatitis continua of Hallopeau with IL-23 blockers -two new cases. Langer N; Wilsmann-Theis D; Kromer C; Mohr J; Mössner R J Dtsch Dermatol Ges; 2021 Oct; 19(10):1504-1507. PubMed ID: 34581001 [No Abstract] [Full Text] [Related]
20. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition. Zhang Z; Wu X; Han C; Chen M; Liu Y J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059 [No Abstract] [Full Text] [Related] [Next] [New Search]